Myelofibrosis: genetic characteristics and the emerging therapeutic landscape

A Tefferi, N Gangat, A Pardanani, JD Crispino - Cancer research, 2022 - AACR
Primary myelofibrosis (PMF) is one of three myeloproliferative neoplasms (MPN) that are
morphologically and molecularly inter-related, the other two being polycythemia vera (PV) …

Megakaryocytes in pulmonary diseases

DY Huang, GM Wang, ZR Ke, Y Zhou, HH Yang, TL Ma… - Life Sciences, 2022 - Elsevier
Megakaryocytes (MKs) are typical cellular components in the circulating blood flowing from
the heart into the lungs. Physiologically, MKs function as an important regulator of platelet …

G6b-B regulates an essential step in megakaryocyte maturation

IC Becker, Z Nagy, G Manukjan… - Blood …, 2022 - ashpublications.org
G6b-B is a megakaryocyte lineage-specific immunoreceptor tyrosine-based inhibition motif–
containing receptor, essential for platelet homeostasis. Mice with a genomic deletion of the …

Identification and validation of long non-coding RNA associated ceRNAs in intrauterine adhesion

J Zhang, P Jiang, Y Tu, N Li, Y Huang, S Jiang… - …, 2022 - Taylor & Francis
Intrauterine adhesion (IUA) is an endometrial fibrotic disease with unclear pathogenesis.
Increasing evidence suggested the important role of competitive endogenous RNA (ceRNA) …

State-of-the-Art review on myelofibrosis therapies

F Wang, T Qiu, H Wang, Q Yang - Clinical Lymphoma Myeloma and …, 2022 - Elsevier
Myelofibrosis (MF) is a BCR-ABL1–negative myeloproliferative neoplasm characterized by
anemia, extramedullary hematopoiesis, bone marrow fibrosis, splenomegaly, constitutional …

Targeting cyclin-dependent kinases 4/6 inhibits survival of megakaryoblasts in acute megakaryoblastic leukaemia

K Qi, X Hu, X Yu, H Cheng, C Wang, S Wang… - Leukemia Research, 2022 - Elsevier
Acute megakaryoblastic leukaemia (AMKL) is characterized by expansion of
megakaryoblasts, which are hyper-proliferative cells that fail to undergo differentiation …

[HTML][HTML] Myelofibrosis treatment history and future prospects

A Ghit - The Egyptian Journal of Internal Medicine, 2022 - Springer
Myelofibrosis (MF) is a haematopoietic stem cell tumour caused by the lack of BCR-ABL
translocation due to point mutations in Janus kinases (JAKs). In previous years, dealing with …

PEDF reduces malignant cells proliferation and inhibits the progression of myelofibrosis in myeloproliferative neoplasms

Y Li, H Gao, H Dong, W Wang, Z Xu, G Wang… - Biochemical …, 2022 - Elsevier
Pigment epithelial-derived factor (PEDF) exerts a broad spectrum of activities and has been
implicated in diverse biological processes and a variety of diseases. However, the role of …

[HTML][HTML] 阻断PAK1 激酶活性对急性巨核细胞白血病细胞分化及凋亡的影响

王淑瑾, 王春晴, 胡雪婷, 于翔茹… - Chinese Journal of …, 2022 - ncbi.nlm.nih.gov
阻断PAK1激酶活性对急性巨核细胞白血病细胞分化及凋亡的影响- PMC Back to Top Skip to
main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content …

Novel strategies for challenging scenarios encountered in managing myelofibrosis

P Bose, RA Mesa - Leukemia & Lymphoma, 2022 - Taylor & Francis
Given its rarity, multi-faceted clinical presentation and the relative paucity of approved
therapies, the management of myeloproliferative neoplasm (MPN)-associated myelofibrosis …